CCO inPractice

|
CCO inPractice Hepatology Apps Now Available
CCO inPractice Hepatology apps are now available for iPad, iPhone, and Android. You can download inPractice to your mobile device for FREE and get the benefit of using inPractice at the point of care. |
CCO Conference Coverage
CCO's independent conference coverage of the 2012 Annual Meeting of the European Association for the Study of the Liver includes a CME-certified slideset with faculty analysis and a downloadable slideset that focuses on key issues highlighted at the conference.
Downloadable PowerPoint Slideset:
 |
Highlights From Barcelona 2012 In this downloadable slideset, Graham R. Foster, FRCP, PhD; David R. Nelson, MD; and Stefan Zeuzem, MD, review the most clinically relevant new data from the 2012 annual meeting of the European Association for the Study of the Liver. |
Treatment Update
Roundtable, 3 Expert Viewpoints, IVP, Slides CME-Certified Interactive Virtual Presentation:
 |
Clinical Implications of HCV Resistance Graham R. Foster, FRCP, PhD, provides expert opinion on how to avoid the development of HCV resistance with new direct-acting antiviral regimens through review of 4 patient cases. | Downloadable PowerPoint Slideset:
CME-Certified Module:
 |
Clinical Implications of HCV Resistance: Laying the Foundation for Optimal Treatment Today and in the Future Join Stephane Chevaliez, PharmD, PhD; Paul J. Pockros, MD; and Stefan Zeuzem, MD, as they review and discuss key principles of HCV resistance with currently approved direct-acting antiviral agents, the latest resistance data on agents in development, and important considerations for potential future anti-HCV regimens. These expert faculty members also provide practical strategies for clinical challenges with the newly approved direct-acting agents through a case-based analysis. | CME-Certified Expert Viewpoints:
Update on HCV Resistance from AASLD 2011 Christoph Sarrazin, MD, reviews highlights on resistance to direct-acting antiviral agents from the 2011 American Association for the Study of Liver Diseases conference. |
Treatment Update
Interactive multimedia presentation and downloadable PowerPoint slides CME-Certified Interactive Virtual Presentation:
 |
Hepatitis B Reactivation: A Largely Preventable Problem In this Interactive Virtual Presentation, Jordan J. Feld, MD, MPH, defines HBV reactivation, the populations for whom HBV screening is recommended, and appropriate steps for treating and monitoring patients to prevent HBV reactivation. | Downloadable PowerPoint Slideset:
 |
Hepatitis B Reactivation: A Largely Preventable Problem In this downloadable slideset, Jordan J. Feld, MD, MPH, highlights the real potential for HBV reactivation in patients undergoing chemotherapy or immunosuppressive therapy, and outlines strategies for appropriate screening, treatment, and management. |
Treatment Update
Downloadable PowerPoint slidesets, available in 8 languages: English, Hmong, Tagalog, Korean, traditional Chinese, simplified Chinese, Burmese, and Cambodian.
Topics include:
-
Overview of Chronic Hepatitis B
-
Candidacy and Guidelines for HBV Therapy
-
Chronic Hepatitis B: Special Populations (coming soon)
Faculty:
Danny Chu, MD Program Director Chul S. Hyun, MD, PhD Charles G. Phan, MD, AGAF
Journal Options
This special edition includes all the pivotal phase III studies of the HCV protease inhibitors, with a range of commentaries exploring key aspects of the use of these agents, plus Capsule Summaries of each study and downloadable slidesets. Topics include:
- Following response-guided therapy guidelines with boceprevir and telaprevir
- Understanding futility rules and their importance
- Outcomes and management of anemia
- Strategies for managing telaprevir rash and anorectal symptoms
- Using boceprevir and telaprevir in patients with advanced fibrosis or cirrhosis
- Effect of telaprevir on cyclosporine and tacrolimus pharmacokinetics
- Antiviral activity with telaprevir in patients with genotype 2 or 3 HCV
- Evaluation of HBV screening cost effectiveness
Treatment Update
PowerPoint slides available for download.
Downloadable PowerPoint Slideset:
Treatment Update
Downloadable Slideset, CME-Certified Case Vignettes
Now Available!
Downloadable PowerPoint Slideset:
CME-Certified Case Vignette:
CCO Official Conference Coverage
CCO's official conference coverage of the 2011 Annual Meeting of the American Association for the Study of Liver Diseases includes a CME-certified slideset with faculty analysis and a downloadable slideset that focuses on key issues highlighted at the conference.
Now Available!
CME-certified slideset:
  |
Highlights of AASLD 2011 In this CME-certified slideset, Raymond T. Chung, MD, and David R. Nelson, MD, review key studies in viral hepatitis from the 2011 American Association for the Study of Liver Diseases meeting. |
Downloadable PowerPoint Slideset:
 |
Highlights of AASLD 2011 In this downloadable slideset, Raymond T. Chung, MD, and David R. Nelson, MD, review key studies of viral hepatitis from the 2011 annual meeting of the American Association for the Study of Liver Diseases.
|
Treatment Update
IVP, downloadable slides, and PDF worksheet
Now Available!
CME-Certified Interactive Virtual Presentation:
Downloadable PowerPoint Slideset:
Downloadable Worksheet:
Treatment Update
Expert faculty recommendations in a text module and slideset.
CME/CE-Certified Module:
Downloadable PowerPoint Slideset:
Treatment Update
Interactive Virtual Presentation, downloadable slides, and downloadable worksheet.
CE-Certified Interactive Virtual Presentation:
Opportunities and Challenges in HCV Management Elizabeth Britton, MSN, reviews the key elements of care for physician assistants and nurse practitioners caring for hepatitis C patients, including the use of newly approved protease inhibitors for treatment of patients infected with HCV genotype 1. | Downloadable PowerPoint Slideset:
Downloadable Pocket Guide:
Annual Update
Expert faculty members review scientific and clinical advances of the past year.
Now Available!
CME/CE-Certified Modules:
 |
Recent Advances in Antiretroviral Therapy Joel E. Gallant, MD, MPH, reviews state-of-the-art management of antiretroviral therapy and discusses the clinical implication of recent data for HIV-infected patients. |
 |
HCV Resistance: Similarities and Differences With HIV Stuart Ray, MD, reviews key similarities and differences between the life cycles and resistance mechanisms of HCV and HIV and explores how these features may impact HCV treatment with newly approved direct-acting antiviral agents. |
 |
Management of Aging HIV-Infected Patients Amy C. Justice, MD, MSc, PhD, discusses the aspects of HIV management affected by aging and describes use of the VACS Index, a tool that may be used to stratify risk in aging patients. |
Downloadable Powerpoint Slideset:
 |
2011 HIV/Hepatitis C Annual Update Download this slideset of selected key figures and tables from the CCO HIV and Hepatitis C Annual Update for use in your personal noncommercial presentations. |
Treatment Update
Interactive Virtual Presentations and downloadable slidesets.
Now Available!
CME-Certified Interactive Virtual Presentations:
 |
On-Treatment Management of Patients With Hepatitis C In this Interactive Virtual Presentation, Graham R. Foster, FRCP, PhD, provides a case-based review of optimal strategies for on-treatment management of patients undergoing therapy for chronic hepatitis C, including an assessment of key decision points during protease inhibitor–based therapy. |
Downloadable PowerPoint Slidesets:
 |
Epidemiology, Screening, and Predictors of Response in HCV In this downloadable slideset, Peter Ferenci, MD, reviews the burden of HCV, recommendations and challenges related to HCV screening, strategies for counseling patients on treatment candidacy, key baseline predictors of response to HCV therapy, and the potential impact of newly approved therapies on HCV management. |
 |
On-Treatment Management of Hepatitis C Patients In this downloadable slideset, Graham R. Foster, FRCP, PhD, provides a case-based review of optimal strategies for on-treatment management of patients undergoing therapy for chronic hepatitis C, including an assessment of key decision points during protease inhibitor–based therapy. |
Treatment Update
Interactive Virtual Presentation, downloadable slideset, and animated flowchart
Now Available!
CME-Certified Interactive Virtual Presentation:
Downloadable PowePoint Slideset:
Animated Flowchart:
CCO Conference Coverage
CCO's independent conference coverage of the 2011 Annual Meeting of the European Association for the Study of the Liver includes Capsule Summaries of key presentations, as well as an Expert Analysis that focuses on key issues highlighted at the conference.
From Podium to Practice: Clinical Impact of New Data From EASL 2011 Graham R. Foster, PhD, FRCP; Paul Y. Kwo, MD; Stefan Zeuzem, MD
Treatment Update
Bimonthly CME-certified audio Podcasts, each supported by a variety of online resources.
|
Browse Hepatitis
New Data
Survival rates at Months 1 and 2 were significantly higher among patients receiving N-acetyl cysteine plus corticosteroid vs those receiving corticosteroid only.
Click here for related capsule summaries
|